Frontier Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-179,806
| Closed | -$4.58M | – | 290 |
|
|
2021
Q3 | $4.58M | Sell |
179,806
-160,626
| -47% | -$4.09M | 0.04% | 260 |
|
|
2021
Q2 | $11.9M | Sell |
340,432
-545,868
| -62% | -$19.1M | 0.09% | 219 |
|
|
2021
Q1 | $36.1M | Buy |
+886,300
| New | +$36.1M | 0.27% | 128 |
|
|
2020
Q3 | – | Sell |
-92,201
| Closed | -$5.82M | – | 304 |
|
|
2020
Q2 | $5.82M | Buy |
92,201
+39,342
| +74% | +$2.48M | 0.05% | 249 |
|
|
2020
Q1 | $2.7M | Sell |
52,859
-81,141
| -61% | -$4.15M | 0.03% | 259 |
|
|
2019
Q4 | $10.7M | Buy |
134,000
+72,816
| +119% | +$5.79M | 0.08% | 220 |
|
|
2019
Q3 | $2.97M | Sell |
61,184
-2,084
| -3% | -$101K | 0.02% | 263 |
|
|
2019
Q2 | $3.33M | Buy |
+63,268
| New | +$3.33M | 0.03% | 273 |
|
|
2018
Q2 | – | Sell |
-191,890
| Closed | -$9.27M | – | 343 |
|
|
2018
Q1 | $9.27M | Buy |
+191,890
| New | +$9.27M | 0.07% | 243 |
|